DNTH

82.6302.59%
MG

Marino Garcia

President, CEO & Director

Mr. Marino Garcia, M.B.A., has been Non-Executive Director of Agomab Therapeutics NV since September 11, 2026. He serves as President and Chief Executive Officer at Dianthus Therapeutics, Inc, since November 2021 and its Director since September 2023 also served as its Secretary until 2024. Mr. Garcia joined Dianthus in November 2021. He served as Senior Vice President of Corporate & Business Development at Zealand Pharma A/S from August 2020 until 2021. He served as Senior Vice President of Business Development, International Commercial & New Product Planning at Zealand Pharma A/S until August 2020. He was Senior Vice President of Corporate & Business Development at Zealand Pharma A/S since October 1, 2018. Mr. Garcia was the Chief Strategy Officer and Executive Vice President at Synergy Pharmaceuticals, Inc. since March 10, 2016 until September 2018. Mr. Garcia served as Senior Vice President of Corporate Development at Synergy Pharmaceuticals, Inc. from March 13, 2014 to March 10, 2016. Mr. Garcia served as Vice President of Global Business Development at Aptalis Pharma, a privately held specialty company focused on the gastrointestinal and cystic fibrosis markets. From 2006 to 2010, Mr. Garcia served as Vice President of US Commercial Operations and New Product Development at Aspreva Pharmaceuticals, which was acquired by Zurich-based Vifor Pharmaceuticals in 2008. Earlier in his career, he served in various U.S. and International leadership roles of increasing responsibility at Eli Lilly & Co, Schering Plough and Pfizer. Mr. Garcia received a Bachelor of Commerce from Concordia University in Montreal, Quebec and an M.B.A. from the Richard Ivey School of Business at Western University in London, Ontario.

Positions